Bifunctional Peptide Nanofibrils for Targeted Protein Degradation

Angew Chem Int Ed Engl. 2024 Jan 15;63(3):e202316581. doi: 10.1002/anie.202316581. Epub 2023 Dec 14.

Abstract

Proteolysis targeting chimera (PROTAC) is a state-of-the-art technology for ablating undruggable targets. A PROTAC degrader achieves targeted protein degradation (TPD) through the simultaneous binding of a protein of interest (POI) and an E3 ligase to form a ternary complex. A nanofibril-based PROTAC strategy to form a polynary (E3)m : PROTAC : (POI)n complex has not been reported in the TPD field up to this point. A recent innovation shows that a POI ligand and E3 ligase ligand don't have to be within a fused degrader molecule. Instead, they can be recruited to cellular proximity by a self-assembly-driving peptide and click chemistry. The resulting nanofibrils can recruit multiple POI and E3 ligase molecules to form a polynary complex as a degradation center. The so-called Nano-PROTAC provides a novel approach for TPD in cancer therapy.

Keywords: Cancer; Nanofibril; PROTAC; Self-Assembly; Targeted Protein Degradation.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Ligands
  • Peptides* / metabolism
  • Proteolysis
  • Ubiquitin-Protein Ligases* / metabolism

Substances

  • Ligands
  • Ubiquitin-Protein Ligases
  • Peptides